Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasone

Therapeutic Advances in Respiratory Disease

Volumn 3, Issue 2, 2009, Pages 59-63

  Cazzola, Mario ^a   Noschese, Paolo ^b   di Perna, Felice ^c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b CARDARELLI HOSPITAL   (Italy)

^c AORN Sant' Anna and San Sebastiano   (Italy)

Author keywords

COPD; exacerbations; fluticasone; propionate; salmeterol polyvalent mechanical bacterial lysate

Indexed keywords

ANTIBIOTIC AGENT; BACTERIUM LYSATE; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL; ISMIGEN; UNCLASSIFIED DRUG;

ADD ON THERAPY; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; COUGHING; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DYSPNEA; FEMALE; FEVER; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SPUTUM EXAMINATION; TREATMENT DURATION;

ADJUVANTS, IMMUNOLOGIC; AGED; ALBUTEROL; ANDROSTADIENES; BACTERIA; BRONCHODILATOR AGENTS; CELL EXTRACTS; DISEASE PROGRESSION; DRUG COMBINATIONS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 67449126257     PISSN: 17534658     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753465809104677     Document Type: Article

References (16)

1. Blasi, F. (2002) Vaccinoprofilassi delle infezioni respiratorie: efficacia di un lisato batterico per via meccanica. Gior It Mal Tor 56: 85-89.
2. Calverley, P.M., Anderson, J.A., Celli, B., Ferguson, G.T., Jenkins, C., Jones, P.W. et al. (2007) Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356: 775-789.
3. Cazzola, M. (2006) A new bacterial lysate protects by reducing infectious exacerbations in moderate to very severe COPD: a double-blind, randomized, placebo-controlled trial. Trends Med 6: 191-199.
4. Cazzola, M., Rogliani, P. and Curradi, G. (2008) Bacterial extracts for the prevention of acute exacerbations in chronic obstructive pulmonary disease: a point of view. Respir Med 102: 321-327.
5. Celli, B.R. and MacNee, W. (2004) Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23: 932-946.
6. Centanni, S., Pregliasco, F., Bonfatti, C., Mensi, C., Tarsia, P., Guarnieri, R. et al. (1997) Clinical efficacy of a vaccine-immunostimulant combination in the prevention of influenza in patients with chronic obstructive pulmonary disease and chronic asthma. J Chemother 9: 273-278.
7. Cogo, R., Ramponi, A., Scivoletto, G. and Rippoli, R. (2003) Prophylaxis for acute exacerbations of chronic bronchitis using an antibacterial sublingual vaccine obtained through mechanical lysis: a clinical and pharmacoeconomic study. Acta Biol Med 74: 81-87.
8. Hirschmann, J.V. (2000) Do bacteria cause exacerbation of COPD? Chest 118: 193-203.
9. Jindal, S.K., Gupta, D. and Aggarwal, A.N. (2004) Guidelines for management of chronic obstructive pulmonary disease (COPD) in India: a guide for physicians Ind J Chest Dis Allied Sci 46: 137-153.
10. Lanzilli, G., Falchetti, R., Cottarelli, A., Macchi, A., Ungheri, D. and Fuggetta, MP (2006) In vivo effect of an immunostimulating bacterial lysate on human B lymphocytes. Int J Immunopathol Pharmacol 19: 551-559.
11. Martinez, F.J. (2007) Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 4: 647-658.
12. Rabe, K.F., Hurd, S., Anzueto, A., Barnes, P.J., Buist, S.A., Calverley, P. et al. (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176: 532-555.
13. Rosaschino, F. and Cattaneo, L. (2004) Strategies for optimizing compliance of paediatric patients for seasonal antibacterial vaccination with sublingually administered polyvalent mechanical bacterial lysates (PMBL). Acta Biomed 75: 171-178.
14. Rossi, G.A., Peri, C., Raynal, M.E., Defilippi, A.C., Risso, F.M., Schenone, G. et al. (2003) Naturally occurring immune response against bacteria commonly involved in upper respiratory tract infections: analysis of the antigen-specific salivary IgA levels. Immunol Lett 86: 85-91.
15. Sole‘r, M. (2005) Modulation of airway inflammation to prevent exacerbations of COPD. Eur Respir Rev 14: 78-82.
16. Steurer-Stey, C., Bachmann, L.M., Steurer, J. and Tramer, M.R. (2004) Oral purified bacterial extracts in chronic bronchitis and COPD: systematic review. Chest 126: 1645-1655.